Yifeng Xia

2.9k total citations · 1 hit paper
38 papers, 2.3k citations indexed

About

Yifeng Xia is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Yifeng Xia has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Biomaterials. Recurrent topics in Yifeng Xia's work include Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (7 papers). Yifeng Xia is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (7 papers). Yifeng Xia collaborates with scholars based in China, United States and Netherlands. Yifeng Xia's co-authors include Inder M. Verma, Shen Shen, Zhiyuan Zhong, Fenghua Meng, Fei Liu, Yan Zou, Narayana Yeddula, Eugene Ke, Beibei Guo and Weijing Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Yifeng Xia

37 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NF-κB, an Active Player in Human Cancers

2014 940 citations Yifeng Xia, Inder M. Verma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yifeng Xia China	23	1.2k	687	564	544	299	38	2.3k
Chalet Tan United States	26	1.2k 0.9×	507 0.7×	351 0.6×	317 0.6×	336 1.1×	47	2.3k
Ommoleila Molavi Iran	27	1.3k 1.0×	388 0.6×	507 0.9×	557 1.0×	541 1.8×	73	2.7k
Yan Fang China	24	1.1k 0.9×	507 0.7×	329 0.6×	350 0.6×	415 1.4×	102	2.3k
Peng Sun China	28	1.3k 1.1×	683 1.0×	350 0.6×	240 0.4×	266 0.9×	114	2.5k
David B. Darr United States	25	1.4k 1.1×	426 0.6×	937 1.7×	470 0.9×	336 1.1×	49	2.7k
Solmaz Shirjang Iran	16	1.5k 1.2×	823 1.2×	498 0.9×	202 0.4×	223 0.7×	18	2.4k
Tahereh Javaheri Austria	16	1.1k 0.9×	547 0.8×	780 1.4×	434 0.8×	295 1.0×	22	2.4k
Ghasem Ghalamfarsa Iran	30	1.0k 0.8×	340 0.5×	708 1.3×	794 1.5×	412 1.4×	64	2.6k
Yiqun G. Shellman United States	26	1.6k 1.3×	489 0.7×	526 0.9×	415 0.8×	110 0.4×	57	2.6k
Neil Vasan United States	10	1.4k 1.1×	592 0.9×	637 1.1×	212 0.4×	202 0.7×	26	2.5k

Countries citing papers authored by Yifeng Xia

Since Specialization

Citations

This map shows the geographic impact of Yifeng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Xia more than expected).

Fields of papers citing papers by Yifeng Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Xia. The network helps show where Yifeng Xia may publish in the future.

Co-authorship network of co-authors of Yifeng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Xia. A scholar is included among the top collaborators of Yifeng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Xia. Yifeng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wan, Peng, Hongyuan Xu, R. Cao, et al.. (2025). A hierarchically porous CoS2-NiS2 heterojunction for high-performance lithium sulfur batteries. Journal of Colloid and Interface Science. 687. 599–606. 7 indexed citations

Cao, R., Guanghui Xu, Yifeng Xia, et al.. (2024). From 0D to 3D: Hierarchical structured high-performance free-standing silicon anodes based on binder-induced topological network architecture. Journal of Energy Chemistry. 93. 16–23. 2 indexed citations

Xu, Hui, R. Cao, Yifeng Xia, et al.. (2024). A novel two-dimensional binder based on functionalized-graphene oxide for high performance Si anodes of Li ion batteries. Journal of Energy Storage. 102. 114038–114038. 3 indexed citations

Wei, Jingjing, Di Wu, Songsong Zhao, et al.. (2022). Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant. Advanced Science. 9(13). e2103689–e2103689. 63 indexed citations

Xia, Yifeng, Jiaying Li, Wenxing Gu, et al.. (2022). Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia. Bioactive Materials. 21. 499–510. 16 indexed citations

Zheng, Huan, Beibei Guo, Xinyun Qiu, et al.. (2022). Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy. Bioactive Materials. 16. 1–11. 56 indexed citations

Xia, Yifeng, Ji X, In Sock Jang, et al.. (2021). Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platform. Communications Biology. 4(1). 834–834. 4 indexed citations

Cao, Shoupeng, Yifeng Xia, Jingxin Shao, et al.. (2021). Biodegradable Polymersomes with Structure Inherent Fluorescence and Targeting Capacity for Enhanced Photo‐Dynamic Therapy. Angewandte Chemie International Edition. 60(32). 17629–17637. 61 indexed citations

Gu, Wenxing, Tianhui Liu, Daoyang Fan, et al.. (2020). A6 peptide-tagged, ultra-small and reduction-sensitive polymersomal vincristine sulfate as a smart and specific treatment for CD44+ acute myeloid leukemia. Journal of Controlled Release. 329. 706–716. 23 indexed citations

10.

Zhou, Cheng, Yifeng Xia, Yaohua Wei, et al.. (2020). GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma. Acta Biomaterialia. 113. 512–521. 30 indexed citations

11.

Zou, Yan, Yinping Sun, Beibei Guo, et al.. (2020). α₃β₁ Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment. ACS Applied Materials & Interfaces. 12(13). 14905–14913. 29 indexed citations

12.

Zhang, Yanmei, et al.. (2019). Molecular Distinguishment of Trapa natans L. Varieties in Taihu Lake Region of China and Development of a RAPD-SCAR Marker for Authentication of ‘Heshangling’. HortScience. 54(8). 1319–1323. 2 indexed citations

13.

Cao, Shoupeng, Jingxin Shao, Yifeng Xia, et al.. (2019). Molecular Programming of Biodegradable Nanoworms via Ionically Induced Morphology Switch toward Asymmetric Therapeutic Carriers. Small. 15(38). e1901849–e1901849. 26 indexed citations

14.

Xia, Yifeng, Cheng Zhan, Mingxiang Feng, et al.. (2018). Targeting CREB Pathway Suppresses Small Cell Lung Cancer. Molecular Cancer Research. 16(5). 825–832. 37 indexed citations

15.

Yang, Weijing, Liang Yang, Yifeng Xia, et al.. (2018). Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo. Acta Biomaterialia. 70. 177–185. 22 indexed citations

16.

Friedmann‐Morvinski, Dinorah, Rajesh Narasimamurthy, Yifeng Xia, et al.. (2016). Targeting NF-κB in glioblastoma: A therapeutic approach. Science Advances. 2(1). e1501292–e1501292. 108 indexed citations

17.

Liu, Fei, et al.. (2012). IKK biology. Immunological Reviews. 246(1). 239–253. 201 indexed citations

18.

Xia, Yifeng, Narayana Yeddula, Mathias Leblanc, et al.. (2012). Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nature Cell Biology. 14(3). 257–265. 111 indexed citations

19.

Suzuki, Kotaro, Yifeng Xia, Masaya Yokota, et al.. (2011). Tumor Suppressor p53 Functions as a Negative Regulator in IgE-Mediated Mast Cell Activation. PLoS ONE. 6(9). e25412–e25412. 10 indexed citations

20.

Kivelä, Annukka M., Petri I. Mäkinen, Henna-Kaisa Jyrkkänen, et al.. (2010). Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells. Atherosclerosis. 213(1). 122–128. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact